Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students

NCT01861613 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2040

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Immune Response
Seroprevalence

Interventions

BIOLOGICAL: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)

Sponsor

Hui Zhuang

Collaborators

[object Object]